VR Logo

Instil Bio Inc. (TIL) download report


Healthcare | Biotechnology & Pharma Research

Instil Bio Inc. (TIL) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer.

IPO Date: 19-Mar-2021

Chairman & CEO: Mr. Bronson Crouch

Chief Technical Officer: Dr. Vijay Chiruvolu M.B.A., Ph.D.

Listing: NASDAQ: TIL

Country: United States

Headquarters: Dallas, TX

Website: https://instilbio.com

Key Facts

Market cap: $618.03 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-187.78 Mln

Cash: $379.52 Mln

Total Debt: $8.44 Mln

Insider's Holding: 2.45%

Liquidity: Low

52 Week range: $3.90 - 23.68

Shares outstanding: 129,294,000

Stock Performance

Time Period Instil Bio (TIL) S&P BSE Sensex S&P Small-Cap 600
YTD-73.00-8.99-19.23
1 month-23.00-3.40-9.35
3 months-61.40-8.50-16.59
1 Year-74.820.89-17.36
3 Years--10.415.90
5 Years--11.435.77
10 Years--11.779.78
As on 30-Jun-2022